HealthData.Gov
The Proliferation REduction with Vascular ENergy Trial (PREVENT)
PREVENT was the first prospective, randomized placebo-controlled study of intracoronary beta radiotherapy with 32P. A total of 105 patients with de novo or restenotic lesions, treated by stenting or balloon angioplasty,…
- HTML
Updated Oct 29, 2026